Cargando…

Bilateral vestibulopathy in anti-IgLON5 disease

Detalles Bibliográficos
Autores principales:	Helmchen, Christoph, Wandinger, Klaus-Peter, Steffen, Armin, Münte, Thomas F., Brüggemann, Norbert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Letter to the Editors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914230/ https://www.ncbi.nlm.nih.gov/pubmed/33484327 http://dx.doi.org/10.1007/s00415-020-10386-5

Ejemplares similares

Patients’ IgLON5 autoantibodies interfere with IgLON5-protein interactions
por: Landa, Jon, et al.
Publicado: (2023)

Corrigendum: Patients’ IgLON5 autoantibodies interfere with IgLON5–protein interactions
por: Landa, Jon, et al.
Publicado: (2023)

Understanding anti-IgLON5 disease
por: Graus, Francesc, et al.
Publicado: (2017)

Bilateral horizontal gaze palsy due to Anti-IgLON5 disease
por: Bhatti, M Tariq
Publicado: (2022)

IgLON5 disease responsive to immunotherapy
por: Bonello, Michael, et al.
Publicado: (2017)

Neuropathological criteria of anti-IgLON5-related tauopathy
por: Gelpi, Ellen, et al.
Publicado: (2016)

Ocular Motor Abnormalities in Anti-IgLON5 Disease
por: Macher, Stefan, et al.
Publicado: (2021)

Early immunotherapy is highly effective in IgG1/IgG4 positive IgLON5 disease
por: Grüter, Thomas, et al.
Publicado: (2020)

Subacute encephalitis with recovery in IgLON5 autoimmunity
por: Ramanan, Vijay K., et al.
Publicado: (2018)

IgLON5 Regulates the Adhesion and Differentiation of Myoblasts
por: Lim, Jeong Ho, et al.
Publicado: (2021)

Isolated dysphagia as initial sign of anti-IgLON5 syndrome
por: Schröder, Jens Burchard, et al.
Publicado: (2016)

Presence of anti-IgLON5 antibody in a case of sporadic Creutzfeldt–Jakob disease with sleep disturbance as a prominent symptom
por: Chen, Zhongyun, et al.
Publicado: (2022)

Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome
por: Sabater, Lidia, et al.
Publicado: (2016)

Immunotherapy improves sleep and cognitive impairment in anti-IgLON5 encephalopathy
por: Brunetti, Valerio, et al.
Publicado: (2019)

Anti-IgLON5 Disease – The Current State of Knowledge and Further Perspectives
por: Madetko, Natalia, et al.
Publicado: (2022)

Anti-IgLON5 disease: a novel topic beyond neuroimmunology
por: Zhang, Yi-ZongHeng, et al.
Publicado: (2022)

Trigeminal Nerve Involvement in Bulbar-Onset Anti-IgLON5 Disease
por: Cluse, Florent, et al.
Publicado: (2023)

Molecular Evolution and Functional Divergence of the IgLON Family
por: Kubick, Norwin, et al.
Publicado: (2018)

Anti‐IgLON5 Disease with Isolated Hemichorea: A Case Report and Review of the Literature
por: Grossauer, Anna, et al.
Publicado: (2022)

Anti-IgLON5 antibodies cause progressive behavioral and neuropathological changes in mice
por: Ni, You, et al.
Publicado: (2022)

Anti-IgLON5 disease complicated with rectal adenocarcinoma: a case report
por: Li, Yi, et al.
Publicado: (2023)

Das Anti-IgLON5-Syndrom in der klinischen Neurologie – zwei Fallberichte
por: Niederschweiberer, Johanna, et al.
Publicado: (2022)

Sleep disorder, chorea, and dementia associated with IgLON5 antibodies
por: Simabukuro, Mateus M., et al.
Publicado: (2015)

IgLON5 antibody: Neurological accompaniments and outcomes in 20 patients
por: Honorat, Josephe A., et al.
Publicado: (2017)

Case Report: Neuropsychological Findings in IgLON5 Antibody Disorder
por: El Shazly, Jasmin, et al.
Publicado: (2021)

The Role of IgLON Cell Adhesion Molecules in Neurodegenerative Diseases
por: Salluzzo, Marco, et al.
Publicado: (2023)

Improvement in mild anti-IgLON5 encephalopathy without immunotherapy: a case report
por: Wang, Yuting, et al.
Publicado: (2021)

Delayed Benefit From Aggressive Immunotherapy in Waxing and Waning Anti-IgLON5 Disease
por: Shambrook, Pauline, et al.
Publicado: (2021)

Anti-IgLON5 disease exacerbated by asymptomatic SARS-CoV-2 infection
por: Li, Xiaoyang, et al.
Publicado: (2023)

Head impulse testing in bilateral vestibulopathy in patients with genetically defined CANVAS
por: Borsche, Max, et al.
Publicado: (2022)

Anti-IgLON5 Disease: A Case With 11-Year Clinical Course and Review of the Literature
por: Nissen, Mette Scheller, et al.
Publicado: (2019)

Anti-IgLON5 Disease: A New Bulbar-Onset Motor Neuron Mimic Syndrome
por: Werner, Jana, et al.
Publicado: (2021)

Neuroimaging Findings in a Patient with Anti-IgLON5 Disease: Cerebrospinal Fluid Dynamics Abnormalities
por: Urso, Daniele, et al.
Publicado: (2022)

Autoimmune encephalitis with anti-IgLON5 and anti-GABA(B)-receptor antibodies: A case report
por: Chung, Ha-Yeun, et al.
Publicado: (2019)

Case report: Anti-IgLON5 disease and anti-LGI1 encephalitis following COVID-19
por: Li, Yanfei, et al.
Publicado: (2023)

HLA and microtubule-associated protein tau H1 haplotype associations in anti-IgLON5 disease
por: Gaig, Carles, et al.
Publicado: (2019)

Increased Intrathecal B and Plasma Cells in Patients With Anti-IgLON5 Disease: A Case Series
por: Strippel, Christine, et al.
Publicado: (2022)

Anti-IgLON5 disease with distinctive brain MRI findings responding to immunotherapy: A case report
por: Pi, Yan, et al.
Publicado: (2021)

Pilot Study of the Effects of Chronic Intracerebroventricular Infusion of Human Anti-IgLON5 Disease Antibodies in Mice
por: Alvente, Sara, et al.
Publicado: (2022)

Analysis of inflammatory markers and tau deposits in an autopsy series of nine patients with anti-IgLON5 disease
por: Berger-Sieczkowski, Evelyn, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fsmprsgfb89le9tfs8ec2kn1oh